Skip to main content
. 2022 Aug 19;13:964118. doi: 10.3389/fimmu.2022.964118

Figure 3.

Figure 3

Identification of necroptosis subtypes and clinicopathological characteristics in TNBC. (A). Interactions and prognostic value of NRGs; (B). Consensus matrix heatmap defining two necroptosis subtypes (k = 2). (C). The Kaplan-Meier analysis for OS of two necroptosis subtypes. (D). The PCA analysis of two necroptosis subtypes. (E). Clinicopathologic characteristics and expression levels of NRGs of two necroptosis subtypes. NRGs, necroptosis-related genes; TNBC, triple negative breast cancer; OS, overall survival; PCA, principal components analysis.

HHS Vulnerability Disclosure